News

Blockmate's Hivello Launches Exciting New Token Sale Event

Blockmate's Hivello Launches Exciting New Token Sale Event

Exciting Token Sale from Hivello Holdings Limited

Blockmate Ventures Inc (TSX.V: MATE) proudly announces that its subsidiary, Hivello Holdings Ltd, is launching a public sale of its native token, $HVLO. This innovative approach sets the stage for Hivello to empower users by allowing them to monetize their unused computing power.

Understanding the Hivello Platform

The platform caters to users seeking passive income by enabling them to connect their idle computational resources to third-party networks. It's an enticing opportunity in today's world where maximizing resource utility is essential.

Token Issuance and Structure

Hivello's tokens are being issued by the Swiss-based HVLO Association with authorization from Hivello Holdings Ltd. The sale reflects a unique approach grounded in efficiency and transparency.

Details of the Upcoming Token Sale

The public token sale kicks off with great anticipation. Hosted on innovative platforms like DAOMaker, HyperGPT, and EclipsePad, the sale aims to make investment opportunities accessible for all potential participants from the outset.

$HVLO Token Sale Logistics

Key elements of the $HVLO token sale include:

  • Public Sale Start Date: January 31, 2025
  • Launchpads: DAOMaker, HyperGPT, EclipsePad
  • Unlock Schedule: Initial unlocking of 25% at the Token Generation Event, followed by a one-month cliff, with the remaining tokens vesting over a five-month period. Team tokens will be locked for nine months, ensuring long-term commitment to community interests.

Hivello's Vision for DePIN Mining

With the token sale approaching, Hivello aims to redefine how individuals can contribute to decentralized physical infrastructure networks. This innovative platform allows users to earn rewards seamlessly and provides a path for those who want to join the DePIN ecosystem, even without technical expertise.

Statement from Hivello Leadership

Domenic Carosa, Chairman and Co-founder, expressed pride in Hivello's growing community. He highlighted the shift towards decentralization as a part of empowering individuals in the digital age. The upcoming token sale invites stakeholders to align further with Hivello's progressive vision.

How to Get Involved in the $HVLO Token Sale

For those eager to participate in this unique opportunity, additional details about the token sale, including the official launchpad links, are readily available. Hivello ensures that every participant had equal access to this groundbreaking event.

About Blockmate Ventures Inc.

Blockmate Ventures is pioneering advancements in technology, focusing on sectors like blockchain, AI, and renewable energy. They support burgeoning founders and projects, offering essential resources to ensure successful monetization. Committed to innovation, Blockmate facilitates the growth of projects like Hivello, positioning them at the forefront of their respective industries.

About Hivello

Hivello's primary mission is to simplify access to DePIN projects, making it easier for users to engage with decentralized networks. With an intuitive app that removes technical barriers, users can effortlessly mobilize their idle computers for extra income.

Frequently Asked Questions

What is the Hivello platform?

The Hivello platform allows users to earn passive income by utilizing their unused computing power in decentralized networks.

When does the $HVLO token sale start?

The public token sale for $HVLO begins on January 31, 2025.

Where will the token sale be hosted?

The token sale will be hosted on DAOMaker, HyperGPT, and EclipsePad launchpads.

What is the token unlock schedule?

25% of tokens will unlock at the Token Generation Event, followed by a month-long cliff and five months of gradual vesting.

How can I participate in the token sale?

Interested participants can find more information about the sale through Hivello's official communication channels and launchpad links.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Apani Adds Kelsun Assets to Its Natural Fiber Platform

Updated Category News Views 52

A materials deal with more chemistry than chest-thumping Seaweed and cotton have landed under one roof, which is a lot more interesting than another apparel brand slapping a green label on ordinary fabric. Apani said November 17 it acquired the assets of Keel Labs, bringing Keel's seaweed-based Kelsun fiber alongside Apani's enhanced cotton-cellulose filament technology....

Continue Reading
InPHRED's Award Brings 1310 nm VCSELs Into Focus at IEEE

Updated Category News Views 15

A stubborn mirror problem just put InPHRED on the photonics map. InPHRED, founded in 2023, took the Best Technology award at the inaugural 2026 IEEE Photonics Conference Start-Up Competition, selected from seven finalists. That is a meaningful industry pat on the back, particularly because the company is aiming at a real engineering headache rather than waving around...

Continue Reading
Panduit's AI Cooling Lab Boosts Data Center Innovation

Updated Category News Views 276

Innovation in Cooling: Panduit's Latest Move You hear "AI" and "data center" together and you know it's not gonna be business as usual. Here's Panduit throwing another log on the fire with their newly minted AI Cooling Lab. Panduit's a big cheese in the electrical and network infrastructure world. They've taken their Thermal Lab, given it a face-lift, and now, they’re...

Continue Reading
Ross Pools Joins Forces with Florida Panthers in 2026

Updated Category News Views 345

An Unlikely Team-Up: Pools and Hockey Well, here's one for the books: a South Florida pool company hitching its wagon to an NHL team. Ross Pools, the folks who’ve been carving out backyard oases in the sizzling Florida sun for over two decades, are now officially aligned with the Florida Panthers. Yeah, the same Panthers that snatched the Stanley Cup not once but twice...

Continue Reading
Stand Out For Good Makes a Bold Michigan Avenue Bet

Updated Category News Views 51

A six-floor retail commitment lands with a thud Stand Out For Good is taking on roughly 51,079 square feet at 669 North Michigan Avenue, and nobody should mistake that for a casual expansion. Six levels on Chicago's Magnificent Mile is a proper declaration of intent, especially in a retail district that has endured plenty of empty-window handwringing and big-brand churn....

Continue Reading
Lecanemab Shines in 5-Year Alzheimer's Study at CTAD

Updated Category News Views 184

Latest Lecanemab Results Turn Heads at CTAD 2026 The whispers buzzing out of the CTAD 2026 conference are about something promising for those in the trenches of Alzheimer's research: lecanemab. Yep, it's a name that's been bandied about before, and this time it's the long-term data doing the talking. The five-year results from Eisai and Biogen's lecanemab study are...

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 244

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
Knotch Bets Brands Need Answers, Not More Web Pages

Updated Category News Views 90

Pages are starting to look like expensive filing cabinets A website that cannot answer an agent may soon be expensive wallpaper. That is the blunt premise behind Knotch's Ace for Agents, launched Nov. 17, 2026, and frankly it lands because plenty of big companies have spent years piling pages atop pages until nobody can tell which claim is current. Knotch is pitching an...

Continue Reading
Operation Healing Forces Partners with Wounded Warrior

Updated Category News Views 80

Joining Forces for Special Operations Families When it comes to the heavy lifting of supporting Special Operations Forces (SOF) families, two powerhouses—Operation Healing Forces (OHF) and Wounded Warrior Project (WWP)—are doubling down. They’re not just tossing around good intentions. Oh no, they’re pulling out the stops with a solid partnership focused on...

Continue Reading
Fuel Cell Market Faces Uneven Growth Amid Revenue Shifts

Updated Category News Views 144

Fuel Cell Sector Eyes Mixed Results and Big Projections The fuel cell market, oh what a beast it's becoming—a story filled with ups and downs, and more forecasts than a weather station. As we stand, this sector is poised to balloon to an $18.16 billion market by 2030. That's a growth rate of 26.3% annually, folks. These projections are driving excitement, but the...

Continue Reading

Top 5 Most Recently Viewed Articles

James Lukezic's Triumph: FINRA Case Dismissed, Reputation Restored

Updated Category News Views 278

James Lukezic's Journey to Exoneration NEW YORK – After undergoing extensive hearings, James Lukezic, the Managing Principal of Old Slip Capital Management, has successfully cleared his name of unfounded allegations in a substantial FINRA case. This decision represents a significant milestone for Lukezic, who faced serious accusations surrounding five trades that...

Continue Reading
DraftKings Inc. Reports Impressive Q2 Growth and Strong Future Prospects

Updated Category News Views 175

DraftKings Inc. Achieves Record Revenue in Q2 DraftKings Inc. announced remarkable financial results for the second quarter, showcasing a significant leap in its performance. This includes a record revenue of $1.51 billion, representing a 37% increase year-over-year. This impressive growth surpassed analyst expectations, as the consensus estimate was only $1.39 billion....

Continue Reading
Trellis Bioscience's $9M Shot at Revolutionizing PJI Treatment

Updated Category News Views 40

New Hope on the Horizon for Joint Implant Infections When you hear about prosthetic joint infections (PJIs), 'devastating' doesn’t quite cover it. We’re talking something that’s hard to tackle, ends up costlier than a Beverly Hills tax bill, and drains quality of life like nothing else. Now, Trellis Bioscience seems to think there's hope on the way. The company just...

Continue Reading
Dionisio Gutiérrez Honored with Prestigious Award by Spain's King

Updated Category News Views 196

Dionisio Gutiérrez's Recognition and Achievements Dionisio Gutiérrez, a prominent figure known for his contributions to civic and business advancements, has recently been honored with the XI Enrique V. Iglesias Award. This prestigious accolade, presented by King Felipe VI of Spain, acknowledges Gutiérrez's significant impact within the Ibero-American space,...

Continue Reading
Vivani Medical Advances in Clinical Trials for GLP-1 Implant

Updated Category News Views 238

Vivani Medical, Inc. (NASDAQ: VANI) recently received approval from the Bellberry Human Research Ethics Committee and an acknowledgment from Australia’s Therapeutic Goods Administration for its first-in-human clinical trial. This significant step centers around the company's innovative GLP-1 (exenatide) implant targeting overweight and obese individuals, marking a...

Continue Reading